{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:22:21Z","timestamp":1784100141328,"version":"3.55.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T00:00:00Z","timestamp":1440115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00281-015-0513-5","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T13:47:35Z","timestamp":1440078455000},"page":"529-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Functional autoantibodies in systemic sclerosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Jeannine","family":"G\u00fcnther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Siegert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,21]]},"reference":[{"issue":"3","key":"513_CR1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","volume":"12","author":"S Mehra","year":"2013","unstructured":"Mehra S, Walker J, Patterson K, Fritzler MJ (2013) Autoantibodies in systemic sclerosis. Autoimmun Rev 12(3):340\u2013354. doi: 10.1016\/j.autrev.2012.05.011","journal-title":"Autoimmun Rev"},{"issue":"1","key":"513_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1024\/0301-1526\/a000065","volume":"40","author":"P Klein-Weigel","year":"2011","unstructured":"Klein-Weigel P, Opitz C, Riemekasten G (2011) Systemic sclerosis\u2014a systematic overview: part 1\u2014disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance. VASA Z Gefasskrankheiten 40(1):6\u201319. doi: 10.1024\/0301-1526\/a000065","journal-title":"VASA Z Gefasskrankheiten"},{"issue":"1","key":"513_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.autrev.2007.06.001","volume":"7","author":"N Gleicher","year":"2007","unstructured":"Gleicher N, Barad D, Weghofer A (2007) Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev 7(1):42\u201345. doi: 10.1016\/j.autrev.2007.06.001","journal-title":"Autoimmun Rev"},{"key":"513_CR4","doi-asserted-by":"crossref","unstructured":"Smilek DE, St Clair EW (2015) Solving the puzzle of autoimmunity: critical questions. F1000prime reports 7:17. doi: 10.12703\/P7-17","DOI":"10.12703\/P7-17"},{"issue":"2\u20133","key":"513_CR5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12026-013-8396-9","volume":"56","author":"C Perricone","year":"2013","unstructured":"Perricone C, Agmon-Levin N, Ceccarelli F, Valesini G, Anaya JM, Shoenfeld Y (2013) Genetics and autoantibodies. Immunol Res 56(2\u20133):206\u2013219. doi: 10.1007\/s12026-013-8396-9","journal-title":"Immunol Res"},{"issue":"12","key":"513_CR6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1172\/JCI0214873","volume":"109","author":"CM Grimaldi","year":"2002","unstructured":"Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B (2002) Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 109(12):1625\u20131633. doi: 10.1172\/JCI14873","journal-title":"J Clin Invest"},{"issue":"2","key":"513_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.autrev.2008.07.005","volume":"8","author":"C Lunardi","year":"2008","unstructured":"Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A (2008) Human parvovirus B19 infection and autoimmunity. Autoimmun Rev 8(2):116\u2013120. doi: 10.1016\/j.autrev.2008.07.005","journal-title":"Autoimmun Rev"},{"issue":"1","key":"513_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","volume":"155","author":"AM Ercolini","year":"2009","unstructured":"Ercolini AM, Miller SD (2009) The role of infections in autoimmune disease. Clin Exp Immunol 155(1):1\u201315. doi: 10.1111\/j.1365-2249.2008.03834.x","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"513_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","volume":"30","author":"S Kivity","year":"2009","unstructured":"Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Infections and autoimmunity\u2014friends or foes? Trends Immunol 30(8):409\u2013414. doi: 10.1016\/j.it.2009.05.005","journal-title":"Trends Immunol"},{"issue":"7","key":"513_CR10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.autrev.2012.12.005","volume":"12","author":"DP Bogdanos","year":"2013","unstructured":"Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Pouria S, Shoenfeld Y (2013) Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev 12(7):726\u2013740. doi: 10.1016\/j.autrev.2012.12.005","journal-title":"Autoimmun Rev"},{"key":"513_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fimmu.2015.00060","volume":"6","author":"KM Pollard","year":"2015","unstructured":"Pollard KM (2015) Environment, autoantibodies, and autoimmunity. Front Immunol 6:60. doi: 10.3389\/fimmu.2015.00060","journal-title":"Front Immunol"},{"issue":"2","key":"513_CR12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jri.2006.08.084","volume":"73","author":"H Stepan","year":"2007","unstructured":"Stepan H, Wallukat G, Schultheiss HP, Faber R, Walther T (2007) Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? J Reprod Immunol 73(2):130\u2013134. doi: 10.1016\/j.jri.2006.08.084","journal-title":"J Reprod Immunol"},{"issue":"1","key":"513_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.autrev.2006.03.008","volume":"6","author":"WJ Venrooij van","year":"2006","unstructured":"van Venrooij WJ, Zendman AJ, Pruijn GJ (2006) Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev 6(1):37\u201341. doi: 10.1016\/j.autrev.2006.03.008","journal-title":"Autoimmun Rev"},{"issue":"16","key":"513_CR14","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526\u20131533. doi: 10.1056\/NEJMoa021933","journal-title":"N Engl J Med"},{"issue":"1","key":"513_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/art.1780340111","volume":"34","author":"ES Weiner","year":"1991","unstructured":"Weiner ES, Hildebrandt S, Senecal JL, Daniels L, Noell S, Joyal F, Roussin A, Earnshaw W, Rothfield NF (1991) Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud\u2019s disease. A prospective study. Arthritis Rheum 34(1):68\u201377","journal-title":"Arthritis Rheum"},{"issue":"1","key":"513_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","volume":"35","author":"VD Steen","year":"2005","unstructured":"Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35(1):35\u201342. doi: 10.1016\/j.semarthrit.2005.03.005","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"513_CR17","first-page":"1643","volume":"32","author":"JL Senecal","year":"2005","unstructured":"Senecal JL, Henault J, Raymond Y (2005) The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma). J Rheumatol 32(9):1643\u20131649","journal-title":"J Rheumatol"},{"issue":"6","key":"513_CR18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66(6):754\u2013763. doi: 10.1136\/ard.2006.062901","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"513_CR19","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","volume":"71","author":"FM Meier","year":"2012","unstructured":"Meier FM, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, Allanore Y, Distler O, Riemekasten G, Valentini G, Muller-Ladner U, Co-authors E (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 71(8):1355\u20131360. doi: 10.1136\/annrheumdis-2011-200742","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"513_CR20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.21646","volume":"54","author":"J Henault","year":"2006","unstructured":"Henault J, Robitaille G, Senecal JL, Raymond Y (2006) DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum 54(3):963\u2013973. doi: 10.1002\/art.21646","journal-title":"Arthritis Rheum"},{"issue":"3","key":"513_CR21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.33377","volume":"64","author":"J Arcand","year":"2012","unstructured":"Arcand J, Robitaille G, Koenig M, Senecal JL, Raymond Y (2012) The autoantigen DNA topoisomerase I interacts with chemokine receptor 7 and exerts cytokine-like effects on dermal fibroblasts. Arthritis Rheum 64(3):826\u2013834. doi: 10.1002\/art.33377","journal-title":"Arthritis Rheum"},{"issue":"4","key":"513_CR22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","volume":"67","author":"Y Hamaguchi","year":"2015","unstructured":"Hamaguchi Y, Kodera M, Matsushita T, Hasegawa M, Inaba Y, Usuda T, Kuwana M, Takehara K, Fujimoto M (2015) Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase iii autoantibodies. Arthritis Rheumatol 67(4):1045\u20131052. doi: 10.1002\/art.38994","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"513_CR23","first-page":"211","volume":"20","author":"JL Senecal","year":"1993","unstructured":"Senecal JL, Ichiki S, Girard D, Raymond Y (1993) Autoantibodies to nuclear lamins and to intermediate filament proteins: natural, pathologic or pathogenic? J Rheumatol 20(2):211\u2013219","journal-title":"J Rheumatol"},{"key":"513_CR24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.iy.11.040193.000455","volume":"11","author":"Y Naparstek","year":"1993","unstructured":"Naparstek Y, Plotz PH (1993) The role of autoantibodies in autoimmune disease. Annu Rev Immunol 11:79\u2013104. doi: 10.1146\/annurev.iy.11.040193.000455","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"513_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00281-014-0425-9","volume":"36","author":"G Wallukat","year":"2014","unstructured":"Wallukat G, Schimke I (2014) Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases. Semin Immunopathol 36(3):351\u2013363. doi: 10.1007\/s00281-014-0425-9","journal-title":"Semin Immunopathol"},{"issue":"11","key":"513_CR26","first-page":"958","volume":"50","author":"IM Roitt","year":"1957","unstructured":"Roitt IM, Doniach D (1957) Auto-immunization in thyroid diseases. Proc R Soc Med 50(11):958\u2013961","journal-title":"Proc R Soc Med"},{"issue":"6","key":"513_CR27","first-page":"437","volume":"52","author":"GA Smart","year":"1959","unstructured":"Smart GA (1959) Discussion on the importance of auto-antibody disease in clinical medicine; introduction: renal and thyroid diseases. Proc R Soc Med 52(6):437\u2013440","journal-title":"Proc R Soc Med"},{"issue":"1","key":"513_CR28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1210\/endo-113-1-436","volume":"113","author":"MN Islam","year":"1983","unstructured":"Islam MN, Briones-Urbina R, Bako G, Farid NR (1983) Both TSH and thyroid-stimulating antibody of Graves\u2019 disease bind to an Mr 197,000 holoreceptor. Endocrinology 113(1):436\u2013438. doi: 10.1210\/endo-113-1-436","journal-title":"Endocrinology"},{"issue":"3","key":"513_CR29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1530\/acta.0.1050330","volume":"105","author":"TW Bruin de","year":"1984","unstructured":"de Bruin TW, van der Heide D (1984) Anti-TSH receptor antibodies in Graves\u2019 disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors. Acta Endocrinol (Copenh) 105(3):330\u2013340","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"5","key":"513_CR30","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/jcem-72-5-1142","volume":"72","author":"GK Huber","year":"1991","unstructured":"Huber GK, Safirstein R, Neufeld D, Davies TF (1991) Thyrotropin receptor autoantibodies induce human thyroid cell growth and c-fos activation. J Clin Endocrinol Metab 72(5):1142\u20131147. doi: 10.1210\/jcem-72-5-1142","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"513_CR31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1152\/physiol.00014.2013","volume":"28","author":"FC Luft","year":"2013","unstructured":"Luft FC (2013) Activating autoantibodies and cardiovascular disease. Physiology 28(4):254\u2013261. doi: 10.1152\/physiol.00014.2013","journal-title":"Physiology"},{"issue":"1","key":"513_CR32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/thy.2012.0374","volume":"23","author":"SM McLachlan","year":"2013","unstructured":"McLachlan SM, Rapoport B (2013) Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid Off J Am Thyroid Assoc 23(1):14\u201324. doi: 10.1089\/thy.2012.0374","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"27","key":"513_CR33","doi-asserted-by":"crossref","first-page":"16384","DOI":"10.1074\/jbc.271.27.16384","volume":"271","author":"TE Hebert","year":"1996","unstructured":"Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271(27):16384\u201316392","journal-title":"J Biol Chem"},{"issue":"3","key":"513_CR34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/08916930109007379","volume":"34","author":"J Hoebeke","year":"2001","unstructured":"Hoebeke J (2001) Molecular mechanisms of anti-G-protein-coupled receptor autoantibodies. Autoimmunity 34(3):161\u2013164","journal-title":"Autoimmunity"},{"issue":"6","key":"513_CR35","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0002-8703(05)80182-6","volume":"119","author":"CJ Limas","year":"1990","unstructured":"Limas CJ, Goldenberg IF, Limas C (1990) Influence of anti-beta-receptor antibodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathy. Am Heart J 119(6):1322\u20131328","journal-title":"Am Heart J"},{"issue":"16","key":"513_CR36","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.jacc.2006.11.051","volume":"49","author":"A Staudt","year":"2007","unstructured":"Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A (2007) Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 49(16):1684\u20131692. doi: 10.1016\/j.jacc.2006.11.051","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"513_CR37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","volume":"3","author":"KL Pierce","year":"2002","unstructured":"Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3(9):639\u2013650. doi: 10.1038\/nrm908","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"513_CR38","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1161\/01.CIR.98.22.2470","volume":"98","author":"S Podlowski","year":"1998","unstructured":"Podlowski S, Luther HP, Morwinski R, Muller J, Wallukat G (1998) Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes. Circulation 98(22):2470\u20132476","journal-title":"Circulation"},{"issue":"4","key":"513_CR39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/art.24364","volume":"60","author":"D Dragun","year":"2009","unstructured":"Dragun D, Distler JH, Riemekasten G, Distler O (2009) Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: what functional autoimmunity could learn from receptor biology. Arthritis Rheum 60(4):907\u2013911. doi: 10.1002\/art.24364","journal-title":"Arthritis Rheum"},{"issue":"25","key":"513_CR40","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","volume":"354","author":"SS Baroni","year":"2006","unstructured":"Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354(25):2667\u20132676. doi: 10.1056\/NEJMoa052955","journal-title":"N Engl J Med"},{"issue":"6","key":"513_CR41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.coi.2007.11.004","volume":"19","author":"A Gabrielli","year":"2007","unstructured":"Gabrielli A, Svegliati S, Moroncini G, Avvedimento EV (2007) Pathogenic autoantibodies in systemic sclerosis. Curr Opin Immunol 19(6):640\u2013645. doi: 10.1016\/j.coi.2007.11.004","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"513_CR42","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.24381","volume":"60","author":"JF Classen","year":"2009","unstructured":"Classen JF, Henrohn D, Rorsman F, Lennartsson J, Lauwerys BR, Wikstrom G, Rorsman C, Lenglez S, Franck-Larsson K, Tomasi JP, Kampe O, Vanthuyne M, Houssiau FA, Demoulin JB (2009) Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis Rheum 60(4):1137\u20131144. doi: 10.1002\/art.24381","journal-title":"Arthritis Rheum"},{"issue":"4","key":"513_CR43","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","volume":"60","author":"N Loizos","year":"2009","unstructured":"Loizos N, Lariccia L, Weiner J, Griffith H, Boin F, Hummers L, Wigley F, Kussie P (2009) Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera. Arthritis Rheum 60(4):1145\u20131151. doi: 10.1002\/art.24365","journal-title":"Arthritis Rheum"},{"issue":"5","key":"513_CR44","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/s10165-010-0310-x","volume":"20","author":"K Kurasawa","year":"2010","unstructured":"Kurasawa K, Arai S, Owada T, Maezawa R, Kumano K, Fukuda T (2010) Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus. Mod Rheumatol Japan Rheum Assoc 20(5):458\u2013465. doi: 10.1007\/s10165-010-0310-x","journal-title":"Mod Rheumatol Japan Rheum Assoc"},{"key":"513_CR45","author":"G Moroncini","year":"2015","unstructured":"Moroncini G, Grieco A, Nacci G, Paolini C, Tonnini C, Pozniak KN, Cuccioloni M, Mozzicafreddo M, Svegliati S, Angeletti M, Kazlauskas A, Avvedimento EV, Funaro A, Gabrielli A (2015) Epitope specificity determines pathogenicity and detectability of anti-PDGFRalpha autoantibodies in systemic sclerosis. Arthritis Rheumatol. doi: 10.1002\/art.39125","journal-title":"Arthritis Rheumatol"},{"issue":"22","key":"513_CR46","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1073\/pnas.0802896105","volume":"105","author":"Y Yang","year":"2008","unstructured":"Yang Y, Yuzawa S, Schlessinger J (2008) Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization. Proc Natl Acad Sci U S A 105(22):7681\u20137686. doi: 10.1073\/pnas.0802896105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"513_CR47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141(7):1117\u20131134. doi: 10.1016\/j.cell.2010.06.011","journal-title":"Cell"},{"issue":"Pt B","key":"513_CR48","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jsbmb.2014.07.004","volume":"144","author":"E Ortona","year":"2014","unstructured":"Ortona E, Pierdominici M, Berstein L (2014) Autoantibodies to estrogen receptors and their involvement in autoimmune diseases and cancer. J Steroid Biochem Mol Biol 144(Pt B):260\u2013267. doi: 10.1016\/j.jsbmb.2014.07.004","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"513_CR49","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.174.4.1775","volume":"174","author":"CM Grimaldi","year":"2005","unstructured":"Grimaldi CM, Hicks R, Diamond B (2005) B cell selection and susceptibility to autoimmunity. J Immunol 174(4):1775\u20131781","journal-title":"J Immunol"},{"issue":"6","key":"513_CR50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.steroids.2012.12.006","volume":"78","author":"K Ueda","year":"2013","unstructured":"Ueda K, Karas RH (2013) Emerging evidence of the importance of rapid, non-nuclear estrogen receptor signaling in the cardiovascular system. Steroids 78(6):589\u2013596. doi: 10.1016\/j.steroids.2012.12.006","journal-title":"Steroids"},{"issue":"2","key":"513_CR51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","volume":"294","author":"S Kovats","year":"2015","unstructured":"Kovats S (2015) Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol 294(2):63\u201369. doi: 10.1016\/j.cellimm.2015.01.018","journal-title":"Cell Immunol"},{"issue":"1\u20132","key":"513_CR52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2010.06.003","volume":"132","author":"M Pierdominici","year":"2010","unstructured":"Pierdominici M, Maselli A, Colasanti T, Giammarioli AM, Delunardo F, Vacirca D, Sanchez M, Giovannetti A, Malorni W, Ortona E (2010) Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 132(1\u20132):79\u201385. doi: 10.1016\/j.imlet.2010.06.003","journal-title":"Immunol Lett"},{"issue":"2","key":"513_CR53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/jcem-64-2-246","volume":"64","author":"A Mudarris","year":"1987","unstructured":"Mudarris A, Peck EJ Jr (1987) Human anti-estrogen receptor antibodies: assay, characterization, and age- and sex-related differences. J Clin Endocrinol Metab 64(2):246\u2013254. doi: 10.1210\/jcem-64-2-246","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"513_CR54","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/art.33400","volume":"64","author":"T Colasanti","year":"2012","unstructured":"Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C, Vacirca D, Tinari A, Chiarotti F, Giovannetti A, Franconi F, Valesini G, Malorni W, Pierdominici M, Ortona E (2012) Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum 64(3):778\u2013787. doi: 10.1002\/art.33400","journal-title":"Arthritis Rheum"},{"issue":"9","key":"513_CR55","doi-asserted-by":"crossref","first-page":"e74332","DOI":"10.1371\/journal.pone.0074332","volume":"8","author":"A Giovannetti","year":"2013","unstructured":"Giovannetti A, Maselli A, Colasanti T, Rosato E, Salsano F, Pisarri S, Mezzaroma I, Malorni W, Ortona E, Pierdominici M (2013) Autoantibodies to estrogen receptor alpha in systemic sclerosis (SSc) as pathogenetic determinants and markers of progression. PloS One 8(9):e74332. doi: 10.1371\/journal.pone.0074332","journal-title":"PloS One"},{"issue":"7","key":"513_CR56","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","volume":"103","author":"G Wallukat","year":"1999","unstructured":"Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103(7):945\u2013952. doi: 10.1172\/JCI4106","journal-title":"J Clin Invest"},{"issue":"1","key":"513_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2009.05.004","volume":"133","author":"Y Xia","year":"2009","unstructured":"Xia Y, Kellems RE (2009) Is preeclampsia an autoimmune disease? Clin Immunol 133(1):1\u201312. doi: 10.1016\/j.clim.2009.05.004","journal-title":"Clin Immunol"},{"issue":"7","key":"513_CR58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00004872-200018070-00017","volume":"18","author":"ML Fu","year":"2000","unstructured":"Fu ML, Herlitz H, Schulze W, Wallukat G, Micke P, Eftekhari P, Sjogren KG, Hjalmarson A, Muller-Esterl W, Hoebeke J (2000) Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 18(7):945\u2013953","journal-title":"J Hypertens"},{"issue":"6","key":"513_CR59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","volume":"352","author":"D Dragun","year":"2005","unstructured":"Dragun D, Muller DN, Brasen JH, Fritsche L, Nieminen-Kelha M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schonemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352(6):558\u2013569. doi: 10.1056\/NEJMoa035717","journal-title":"N Engl J Med"},{"issue":"3","key":"513_CR60","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","volume":"70","author":"G Riemekasten","year":"2011","unstructured":"Riemekasten G, Philippe A, Nather M, Slowinski T, Muller DN, Heidecke H, Matucci-Cerinic M, Czirjak L, Lukitsch I, Becker M, Kill A, van Laar JM, Catar R, Luft FC, Burmester GR, Hegner B, Dragun D (2011) Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 70(3):530\u2013536. doi: 10.1136\/ard.2010.135772","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"513_CR61","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","volume":"190","author":"MO Becker","year":"2014","unstructured":"Becker MO, Kill A, Kutsche M, Guenther J, Rose A, Tabeling C, Witzenrath M, Kuhl AA, Heidecke H, Ghofrani HA, Tiede H, Schermuly RT, Nickel N, Hoeper MM, Lukitsch I, Gollasch M, Kuebler WM, Bock S, Burmester GR, Dragun D, Riemekasten G (2014) Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Am J Respir Crit Care Med 190(7):808\u2013817. doi: 10.1164\/rccm.201403-0442OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"513_CR62","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","volume":"16","author":"J Gunther","year":"2014","unstructured":"Gunther J, Kill A, Becker MO, Heidecke H, Rademacher J, Siegert E, Radic M, Burmester GR, Dragun D, Riemekasten G (2014) Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients. Arthritis Res Ther 16(2):R65. doi: 10.1186\/ar4503","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"513_CR63","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","volume":"16","author":"A Kill","year":"2014","unstructured":"Kill A, Tabeling C, Undeutsch R, Kuhl AA, Gunther J, Radic M, Becker MO, Heidecke H, Worm M, Witzenrath M, Burmester GR, Dragun D, Riemekasten G (2014) Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Arthritis Res Ther 16(1):R29. doi: 10.1186\/ar4457","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"513_CR64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0b013e32833038ce","volume":"21","author":"M Trojanowska","year":"2009","unstructured":"Trojanowska M (2009) Noncanonical transforming growth factor beta signaling in scleroderma fibrosis. Curr Opin Rheumatol 21(6):623\u2013629. doi: 10.1097\/BOR.0b013e32833038ce","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"513_CR65","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1172\/JCI107827","volume":"54","author":"EC LeRoy","year":"1974","unstructured":"LeRoy EC (1974) Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 54(4):880\u2013889. doi: 10.1172\/JCI107827","journal-title":"J Clin Invest"},{"issue":"3","key":"513_CR66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1042\/bj2370837","volume":"237","author":"SA Jimenez","year":"1986","unstructured":"Jimenez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J (1986) Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J 237(3):837\u2013843","journal-title":"Biochem J"},{"issue":"7","key":"513_CR67","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","volume":"173","author":"A Prasse","year":"2006","unstructured":"Prasse A, Pechkovsky DV, Toews GB, Jungraithmayr W, Kollert F, Goldmann T, Vollmer E, Muller-Quernheim J, Zissel G (2006) A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 173(7):781\u2013792. doi: 10.1164\/rccm.200509-1518OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"513_CR68","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2353\/ajpath.2007.061167","volume":"171","author":"K Pochetuhen","year":"2007","unstructured":"Pochetuhen K, Luzina IG, Lockatell V, Choi J, Todd NW, Atamas SP (2007) Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol 171(2):428\u2013437. doi: 10.2353\/ajpath.2007.061167","journal-title":"Am J Pathol"},{"issue":"5","key":"513_CR69","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1183\/09031936.00131713","volume":"43","author":"J Schupp","year":"2014","unstructured":"Schupp J, Becker M, Gunther J, Muller-Quernheim J, Riemekasten G, Prasse A (2014) Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis. Eur Respir J 43(5):1530\u20131532. doi: 10.1183\/09031936.00131713","journal-title":"Eur Respir J"},{"issue":"5\u20136","key":"513_CR70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000163802","volume":"61","author":"AE Koch","year":"1993","unstructured":"Koch AE, Kronfeld-Harrington LB, Szekanecz Z, Cho MM, Haines GK, Harlow LA, Strieter RM, Kunkel SL, Massa MC, Barr WG et al (1993) In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiol J Immunopathol Mol Cell Biol 61(5\u20136):239\u2013246","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"issue":"1","key":"513_CR71","first-page":"151","volume":"39","author":"S Bacman","year":"1998","unstructured":"Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren\u2019s syndrome. Invest Ophthalmol Vis Sci 39(1):151\u2013156","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"513_CR72","first-page":"247","volume":"6","author":"R Patel","year":"2014","unstructured":"Patel R, Shahane A (2014) The epidemiology of Sjogren\u2019s syndrome. Clin Epidemiol 6:247\u2013255. doi: 10.2147\/CLEP.S47399","journal-title":"Clin Epidemiol"},{"issue":"4","key":"513_CR73","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1053\/gast.2002.36057","volume":"123","author":"F Goldblatt","year":"2002","unstructured":"Goldblatt F, Gordon TP, Waterman SA (2002) Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 123(4):1144\u20131150","journal-title":"Gastroenterology"},{"issue":"6","key":"513_CR74","doi-asserted-by":"crossref","first-page":"G1206","DOI":"10.1152\/ajpgi.00286.2009","volume":"297","author":"J Singh","year":"2009","unstructured":"Singh J, Mehendiratta V, Del Galdo F, Jimenez SA, Cohen S, DiMarino AJ, Rattan S (2009) Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 297(6):G1206\u2013G1213. doi: 10.1152\/ajpgi.00286.2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"513_CR75","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1053\/j.gastro.2012.07.109","volume":"143","author":"J Singh","year":"2012","unstructured":"Singh J, Cohen S, Mehendiratta V, Mendoza F, Jimenez SA, Dimarino AJ, Rattan S (2012) Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function. Gastroenterology 143(5):1308\u20131318. doi: 10.1053\/j.gastro.2012.07.109","journal-title":"Gastroenterology"},{"issue":"3","key":"513_CR76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0300-9475.2004.01395.x","volume":"59","author":"D Cavill","year":"2004","unstructured":"Cavill D, Waterman SA, Gordon TP (2004) Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren\u2019s syndrome. Scand J Immunol 59(3):261\u2013266. doi: 10.1111\/j.0300-9475.2004.01395.x","journal-title":"Scand J Immunol"},{"issue":"1","key":"513_CR77","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cei.12324","volume":"177","author":"B Preuss","year":"2014","unstructured":"Preuss B, Tunaru S, Henes J, Offermanns S, Klein R (2014) A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients\u2019 sera. Clin Exp Immunol 177(1):179\u2013189. doi: 10.1111\/cei.12324","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"513_CR78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/TP.0b013e3182529bb7","volume":"94","author":"I Lukitsch","year":"2012","unstructured":"Lukitsch I, Kehr J, Chaykovska L, Wallukat G, Nieminen-Kelha M, Batuman V, Dragun D, Gollasch M (2012) Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies. Transplantation 94(1):8\u201313. doi: 10.1097\/TP.0b013e3182529bb7","journal-title":"Transplantation"},{"issue":"1","key":"513_CR79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI118377","volume":"97","author":"D Carvalho","year":"1996","unstructured":"Carvalho D, Savage CO, Black CM, Pearson JD (1996) IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 97(1):111\u2013119. doi: 10.1172\/JCI118377","journal-title":"J Clin Invest"},{"issue":"3","key":"513_CR80","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cei.12166","volume":"174","author":"SJ Arends","year":"2013","unstructured":"Arends SJ, Damoiseaux JG, Duijvestijn AM, Debrus-Palmans L, Vroomen M, Boomars KA, Brunner-La Rocca HP, Reutelingsperger CP, Cohen Tervaert JW, van Paassen P (2013) Immunoglobulin G anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension? Clin Exp Immunol 174(3):433\u2013440. doi: 10.1111\/cei.12166","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"513_CR81","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","volume":"6","author":"C Lunardi","year":"2000","unstructured":"Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6(10):1183\u20131186. doi: 10.1038\/80533","journal-title":"Nat Med"},{"issue":"46","key":"513_CR82","doi-asserted-by":"crossref","first-page":"29181","DOI":"10.1074\/jbc.272.46.29181","volume":"272","author":"I Tachibana","year":"1997","unstructured":"Tachibana I, Bodorova J, Berditchevski F, Zutter MM, Hemler ME (1997) NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J Biol Chem 272(46):29181\u201329189","journal-title":"J Biol Chem"},{"issue":"1","key":"513_CR83","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.0030002","volume":"3","author":"C Lunardi","year":"2006","unstructured":"Lunardi C, Dolcino M, Peterlana D, Bason C, Navone R, Tamassia N, Beri R, Corrocher R, Puccetti A (2006) Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Med 3(1):e2. doi: 10.1371\/journal.pmed.0030002","journal-title":"PLoS Med"},{"issue":"1\u20132","key":"513_CR84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2013.05.002","volume":"59","author":"SI Wolf","year":"2013","unstructured":"Wolf SI, Howat S, Abraham DJ, Pearson JD, Lawson C (2013) Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascades. Vasc Pharmacol 59(1\u20132):19\u201326. doi: 10.1016\/j.vph.2013.05.002","journal-title":"Vasc Pharmacol"},{"issue":"6","key":"513_CR85","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","volume":"46","author":"C Chizzolini","year":"2002","unstructured":"Chizzolini C, Raschi E, Rezzonico R, Testoni C, Mallone R, Gabrielli A, Facchini A, Del Papa N, Borghi MO, Dayer JM, Meroni PL (2002) Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 46(6):1602\u20131613. doi: 10.1002\/art.10361","journal-title":"Arthritis Rheum"},{"issue":"4","key":"513_CR86","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","volume":"28","author":"MC Tamby","year":"2006","unstructured":"Tamby MC, Humbert M, Guilpain P, Servettaz A, Dupin N, Christner JJ, Simonneau G, Fermanian J, Weill B, Guillevin L, Mouthon L (2006) Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Respir J 28(4):799\u2013807. doi: 10.1183\/09031936.06.00152705","journal-title":"Eur Respir J"},{"issue":"10","key":"513_CR87","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.200707-1015OC","volume":"177","author":"B Terrier","year":"2008","unstructured":"Terrier B, Tamby MC, Camoin L, Guilpain P, Broussard C, Bussone G, Yaici A, Hotellier F, Simonneau G, Guillevin L, Humbert M, Mouthon L (2008) Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. Am J Respir Crit Care Med 177(10):1128\u20131134. doi: 10.1164\/rccm.200707-1015OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"513_CR88","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.2008.104299","volume":"69","author":"B Terrier","year":"2010","unstructured":"Terrier B, Tamby MC, Camoin L, Guilpain P, Berezne A, Tamas N, Broussard C, Hotellier F, Humbert M, Simonneau G, Guillevin L, Mouthon L (2010) Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease. Ann Rheum Dis 69(2):428\u2013433. doi: 10.1136\/ard.2008.104299","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"513_CR89","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0889-857X(05)70294-5","volume":"22","author":"SA Jimenez","year":"1996","unstructured":"Jimenez SA, Hitraya E, Varga J (1996) Pathogenesis of scleroderma. Collagen. Rheum Dis Clin N Am 22(4):647\u2013674","journal-title":"Rheum Dis Clin N Am"},{"issue":"4","key":"513_CR90","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","volume":"120","author":"S Sato","year":"2003","unstructured":"Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K (2003) Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Investig Dermatol 120(4):542\u2013547. doi: 10.1046\/j.1523-1747.2003.12097.x","journal-title":"J Investig Dermatol"},{"issue":"2","key":"513_CR91","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.2004.02615.x","volume":"138","author":"C Nishijima","year":"2004","unstructured":"Nishijima C, Hayakawa I, Matsushita T, Komura K, Hasegawa M, Takehara K, Sato S (2004) Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis. Clin Exp Immunol 138(2):357\u2013363. doi: 10.1111\/j.1365-2249.2004.02615.x","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"513_CR92","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","volume":"95","author":"D Farge","year":"2010","unstructured":"Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, Ouyang J, Kozak T, Moore J, Kotter I, Chesnel V, Marmont A, Gratwohl A, Saccardi R (2010) Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 95(2):284\u2013292. doi: 10.3324\/haematol.2009.013458","journal-title":"Haematologica"},{"issue":"24","key":"513_CR93","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM Laar van","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kotter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quere I, Rich E, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socie G, Gratwohl A, Tyndall A, Group EESS (2014) Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 311(24):2490\u20132498. doi: 10.1001\/jama.2014.6368","journal-title":"JAMA"},{"issue":"10","key":"513_CR94","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","volume":"6","author":"A Radbruch","year":"2006","unstructured":"Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T, Hiepe F (2006) Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6(10):741\u2013750. doi: 10.1038\/nri1886","journal-title":"Nat Rev Immunol"},{"key":"513_CR95","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1196\/annals.1313.014","volume":"1050","author":"BF Hoyer","year":"2005","unstructured":"Hoyer BF, Manz RA, Radbruch A, Hiepe F (2005) Long-lived plasma cells and their contribution to autoimmunity. Ann N Y Acad Sci 1050:124\u2013133. doi: 10.1196\/annals.1313.014","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"513_CR96","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1136\/ard.2010.148049","volume":"70","author":"GG Illei","year":"2011","unstructured":"Illei GG, Cervera R, Burt RK, Doria A, Hiepe F, Jayne D, Pavletic S, Martin T, Marmont A, Saccardi R, Voskuyl AE, Farge D (2011) Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus. Ann Rheum Dis 70(12):2071\u20132074. doi: 10.1136\/ard.2010.148049","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"513_CR97","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/rheumatology\/keg050","volume":"42","author":"M Humbert","year":"2003","unstructured":"Humbert M, Cabane J (2003) Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan. Rheumatology 42(1):191\u2013193","journal-title":"Rheumatology"},{"issue":"12","key":"513_CR98","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"JH Korn","year":"2004","unstructured":"Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50(12):3985\u20133993. doi: 10.1002\/art.20676","journal-title":"Arthritis Rheum"},{"issue":"5","key":"513_CR99","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2133.2006.07194.x","volume":"154","author":"J Tillon","year":"2006","unstructured":"Tillon J, Herve F, Chevallier D, Muir JF, Levesque H, Marie I (2006) Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy. Br J Dermatol 154(5):1000\u20131002. doi: 10.1111\/j.1365-2133.2006.07194.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"513_CR100","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/art.22634","volume":"56","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Papamichael C, Stamatelopoulos KS, Tousoulis D, Fragiadaki KG, Katsichti P, Stefanadis C, Mavrikakis M (2007) Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum 56(6):1985\u20131993. doi: 10.1002\/art.22634","journal-title":"Arthritis Rheum"},{"issue":"10","key":"513_CR101","first-page":"888","volume":"7","author":"A Ambach","year":"2009","unstructured":"Ambach A, Seo W, Bonnekoh B, Gollnick H (2009) Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil. J Dtsch Dermatol Ges J Ger Soc Dermatol: JDDG 7(10):888\u2013891. doi: 10.1111\/j.1610-0387.2009.07057.x","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol: JDDG"},{"issue":"2","key":"513_CR102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000228318","volume":"219","author":"P Gholam","year":"2009","unstructured":"Gholam P, Sehr T, Enk A, Hartmann M (2009) Successful treatment of systemic-sclerosis-related digital ulcers with a selective endothelin type A receptor antagonist (sitaxentan). Dermatology 219(2):171\u2013173. doi: 10.1159\/000228318","journal-title":"Dermatology"},{"issue":"2","key":"513_CR103","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/j.1440-0960.2010.00719.x","volume":"53","author":"A Nishibu","year":"2012","unstructured":"Nishibu A, Sakai E, Oyama N, Yamamoto T (2012) Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis. Aust J Dermatol 53(2):e32\u2013e33. doi: 10.1111\/j.1440-0960.2010.00719.x","journal-title":"Aust J Dermatol"},{"issue":"5","key":"513_CR104","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3899\/jrheum.131284","volume":"41","author":"M Cutolo","year":"2014","unstructured":"Cutolo M, Ruaro B, Pizzorni C, Ravera F, Smith V, Zampogna G, Paolino S, Seriolo B, Cimmino M, Sulli A (2014) Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. J Rheumatol 41(5):881\u2013886. doi: 10.3899\/jrheum.131284","journal-title":"J Rheumatol"},{"issue":"2","key":"513_CR105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaad.2014.04.028","volume":"71","author":"L Chung","year":"2014","unstructured":"Chung L, Ball K, Yaqub A, Lingala B, Fiorentino D (2014) Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: results of a prospective pilot study. J Am Acad Dermatol 71(2):400\u2013401. doi: 10.1016\/j.jaad.2014.04.028","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"513_CR106","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T","volume":"42","author":"M Dziadzio","year":"1999","unstructured":"Dziadzio M, Denton CP, Smith R, Howell K, Blann A, Bowers E, Black CM (1999) Losartan therapy for Raynaud\u2019s phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum 42(12):2646\u20132655. doi: 10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T","journal-title":"Arthritis Rheum"},{"key":"513_CR107","author":"FM McQueen","year":"2015","unstructured":"McQueen FM, Solanki K (2015) Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today? Rheumatology. doi: 10.1093\/rheumatology\/keu463","journal-title":"Rheumatology"},{"issue":"1","key":"513_CR108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.atherosclerosissup.2012.10.034","volume":"14","author":"B Hohenstein","year":"2013","unstructured":"Hohenstein B, Bornstein SR, Aringer M (2013) Immunoadsorption for connective tissue disease. Atheroscler Suppl 14(1):185\u2013189. doi: 10.1016\/j.atherosclerosissup.2012.10.034","journal-title":"Atheroscler Suppl"},{"issue":"1","key":"513_CR109","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10198-003-0202-5","volume":"5","author":"FP Hessel","year":"2004","unstructured":"Hessel FP, Wegner C, Muller J, Glaveris C, Wasem J (2004) Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Eur J Health Econ: HEPAC: Health Econ Prev Care 5(1):58\u201363. doi: 10.1007\/s10198-003-0202-5","journal-title":"Eur J Health Econ: HEPAC: Health Econ Prev Care"},{"issue":"1","key":"513_CR110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.atherosclerosissup.2012.10.029","volume":"14","author":"M Dandel","year":"2013","unstructured":"Dandel M, Wallukat G, Englert A, Hetzer R (2013) Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension. Atheroscler Suppl 14(1):203\u2013211. doi: 10.1016\/j.atherosclerosissup.2012.10.029","journal-title":"Atheroscler Suppl"},{"issue":"6","key":"513_CR111","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tcm.2012.05.006","volume":"21","author":"A Haberland","year":"2011","unstructured":"Haberland A, Wallukat G, Schimke I (2011) Aptamer binding and neutralization of beta1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment. Trends Cardiovasc Med 21(6):177\u2013182. doi: 10.1016\/j.tcm.2012.05.006","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"513_CR112","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4155\/ppa.12.88","volume":"2","author":"A Haberland","year":"2013","unstructured":"Haberland A, Wallukat G, Schimke I (2013) The patent situation concerning the treatment of diseases associated with autoantibodies directed against G-protein-coupled receptors. Pharm Patent Anal 2(2):231\u2013248. doi: 10.4155\/ppa.12.88","journal-title":"Pharm Patent Anal"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0513-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-015-0513-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0513-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T16:46:15Z","timestamp":1567097175000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-015-0513-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,21]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s00281-015-0513-5","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,21]]}}}